TALEN outperforms Cas9 in editing heterochromatin target sites.

Jain S, Shukla S, Yang C, Zhang M, Fatma Z, Lingamaneni M, Abesteh S, Lane ST, Xiong X, Wang Y, Schroeder CM, Selvin PR, Zhao H
Nat Commun. 2021 Jan 27;12(1):606. doi: 10.1038/s41467-020-20672-5. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.